MeiraGTx Holdings (MGTX) Profit After Tax (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 129.87% |
| Sep 30, 2025 | -30.20% |
| Jun 30, 2025 | 2.97% |
| Mar 31, 2025 | -1.48% |
| Dec 31, 2024 | -0.18% |
| Sep 30, 2024 | 19.11% |
| Jun 30, 2024 | -137.84% |
| Mar 31, 2024 | -201.12% |
| Dec 31, 2023 | 145.64% |
| Sep 30, 2023 | -49.75% |
| Jun 30, 2023 | 2.58% |
| Mar 31, 2023 | -11.17% |
| Dec 31, 2022 | 26.74% |
| Sep 30, 2022 | -9.75% |
| Jun 30, 2022 | -9.43% |
| Mar 31, 2022 | -213.21% |
| Dec 31, 2021 | 61.80% |
| Sep 30, 2021 | -29.17% |
| Jun 30, 2021 | 14.95% |
| Mar 31, 2021 | -125.77% |
| Dec 31, 2020 | -62.64% |
| Sep 30, 2020 | 74.70% |
| Jun 30, 2020 | -62.09% |
| Mar 31, 2020 | -186.09% |
| Dec 31, 2019 | 47.60% |
| Sep 30, 2019 | 49.76% |
| Jun 30, 2019 | -15.80% |
| Mar 31, 2019 | 14.60% |
| Dec 31, 2018 | -36.51% |
| Sep 30, 2018 | 48.55% |
| Jun 30, 2018 | -82.77% |
| Mar 31, 2018 | -90.64% |
| Dec 31, 2017 | -1.93% |
| Sep 30, 2017 | -17.58% |